Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
6-phosphofructokinase deficiency
The contribution of Ca+ calmodulin activation of human erythrocyte AMP deaminase (isoform E) to the erythrocyte metabolic dysregulation of familial phosphofructokinase deficiency.
6-phosphofructokinase deficiency
The contribution of Ca2+-calmodulin activation of human erythrocyte AMP deaminase (isoform E) to the erythrocyte metabolic dysregulation of familial phosphofructokinase deficiency.
Acidosis
Adenine nucleotide degradation in human skeletal muscle during prolonged exercise.
Acidosis
AMP deaminase binding in contracting rat skeletal muscle.
Acidosis
ATP depletion in slow-twitch red muscle of rat.
Acidosis
Influence of acidosis on AMP deaminase activity in contracting fast-twitch muscle.
Acidosis
Muscle glutamine production in diabetic ketoacidotic rats.
Acidosis, Lactic
Clinical disorders of muscle energy metabolism.
Adenocarcinoma
High expression of AMPD2 and obesity are associated with poor prognosis in colorectal cancer.
Alzheimer Disease
Elevated adenosine monophosphate deaminase activity in Alzheimer's disease brain.
amidase deficiency
A Competitive Allele-specific Oligomers Polymerase Chain Reaction Assay for the cis Double Mutation in AMPD1 That Is the Major Cause of Myo-adenylate Deaminase Deficiency.
amidase deficiency
Disruption of the purine nucleotide cycle. A potential explanation for muscle dysfunction in myoadenylate deaminase deficiency.
amidase deficiency
Expression of different isoenzymes of adenylate deaminase in cultured human muscle cells. Relation to myoadenylate deaminase deficiency.
amidase deficiency
Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle.
amidase deficiency
Peripartum anaesthetic management of a patient with Brugada syndrome and myoadenylate deaminase deficiency.
amidase deficiency
Primary Adenosine Monophosphate Deaminase Deficiency in a Hypotonic Infant.
amp deaminase deficiency
A G468-T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population.
amp deaminase deficiency
A point mutation responsible for human erythrocyte AMP deaminase deficiency.
amp deaminase deficiency
A rare case of complete human erythrocyte AMP deaminase deficiency due to two novel missense mutations in AMPD3.
amp deaminase deficiency
Adenine nucleotide metabolism in contracting skeletal muscle.
amp deaminase deficiency
Adenosine inhibits depolarization-induced Ca(2+) release in mammalian skeletal muscle.
amp deaminase deficiency
Adenosine monophosphate deaminase 3 null mutation causes reduction of naive T cells in mouse peripheral blood.
amp deaminase deficiency
Adenylate deaminase deficiency in a hypotonic infant.
amp deaminase deficiency
Adenylate deaminase deficiency in a mutant murine T cell lymphoma cell line.
amp deaminase deficiency
Alternative splicing: a mechanism for phenotypic rescue of a common inherited defect.
amp deaminase deficiency
AMP Deaminase 3 Deficiency Enhanced 5'-AMP Induction of Hypometabolism.
amp deaminase deficiency
AMP deaminase deficiency in skeletal muscle is unlikely to be of clinical relevance.
amp deaminase deficiency
AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects.
amp deaminase deficiency
AMP deaminase deficiency: study of the human skeletal muscle purine metabolism during ischaemic isometric exercise.
amp deaminase deficiency
AMPD1 polymorphism and response to regadenoson.
amp deaminase deficiency
AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle.
amp deaminase deficiency
AMPD2 regulates GTP synthesis and is mutated in a potentially treatable neurodegenerative brainstem disorder.
amp deaminase deficiency
AMPD3 is involved in anthrax LeTx-induced macrophage cell death.
amp deaminase deficiency
AMPD3-deficient mice exhibit increased erythrocyte ATP levels but anemia not improved due to PK deficiency.
amp deaminase deficiency
Association of genetically proven deficiencies of myophosphorylase and AMP deaminase: a second case of 'double trouble'.
amp deaminase deficiency
Beneficial effect of a treatment with xylitol in a patient with myoadenylate deaminase deficiency.
amp deaminase deficiency
Beneficial effect of D-ribose in patient with myoadenylate deaminase deficiency.
amp deaminase deficiency
Biochemical and genetic analysis of AMP deaminase deficiency in cultured mammalian cells.
amp deaminase deficiency
Biochemistry: index of the functional state of the heart?
amp deaminase deficiency
Cardiac involvement in primary myopathies.
amp deaminase deficiency
CD73 and AMPD3 deficiency enhance metabolic performance via erythrocyte ATP that decreases hemoglobin oxygen affinity.
amp deaminase deficiency
Characterization of the human and rat myoadenylate deaminase genes.
amp deaminase deficiency
Chronic non-exertional myalgia and myoadenylate deaminase deficiency: a possible association.
amp deaminase deficiency
Clinical disorders of muscle energy metabolism.
amp deaminase deficiency
Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency.
amp deaminase deficiency
Clinical significance and neuropathology of primary MADD in C34-T and G468-T mutations of the AMPD1 gene.
amp deaminase deficiency
Clinical use of creatine in neuromuscular and neurometabolic disorders.
amp deaminase deficiency
Combined defects of muscle phosphofructokinase and AMP deaminase in a child with myoglobinuria.
amp deaminase deficiency
Correction: AMP Deaminase 3 Deficiency Enhanced 5'-AMP Induction of Hypometabolism.
amp deaminase deficiency
Diagnostic Algorithm for Glycogenoses and Myoadenylate Deaminase Deficiency Based on Exercise Testing Parameters: A Prospective Study.
amp deaminase deficiency
Diagnostic utility of a modified forearm ischemic exercise test and technical issues relevant to exercise testing.
amp deaminase deficiency
Differentiating idiopathic inflammatory myopathies from metabolic myopathies.
amp deaminase deficiency
Disruption of the purine nucleotide cycle. A potential explanation for muscle dysfunction in myoadenylate deaminase deficiency.
amp deaminase deficiency
Double trouble: combined myophosphorylase and AMP deaminase deficiency in a child homozygous for nonsense mutations at both loci.
amp deaminase deficiency
Effect of isolated AMP deaminase deficiency on skeletal muscle function.
amp deaminase deficiency
Effects of AMPD1 common mutation on the metabolic-chronotropic relationship: Insights from patients with myoadenylate deaminase deficiency.
amp deaminase deficiency
Effects of oral ribose on muscle metabolism during bicycle ergometer in AMPD-deficient patients.
amp deaminase deficiency
Ergometer exercise in myoadenylate deaminase deficient patients.
amp deaminase deficiency
Erythrocyte amp deaminase deficiency in Japanese: a compound heterozygote responsible for the complete deficiency.
amp deaminase deficiency
Exercising muscle does not produce hypoxanthine in adenylate deaminase deficiency.
amp deaminase deficiency
Exertional myalgia syndrome associated with diminished serum ammonia elevation in ischemic exercise testing.
amp deaminase deficiency
Exertional rhabdomyolysis: a clinical review with a focus on genetic influences.
amp deaminase deficiency
Expression of different isoenzymes of adenylate deaminase in cultured human muscle cells. Relation to myoadenylate deaminase deficiency.
amp deaminase deficiency
Failure of D-ribose in myoadenylate deaminase deficiency.
amp deaminase deficiency
Familial myoadenylate deaminase deficiency and exertional myalgia.
amp deaminase deficiency
First missense mutations (R388W and R425H) of AMPD1 accompanied with myopathy found in a Japanese patient.
amp deaminase deficiency
Gene mutations for human erythrocyte AMP deaminase deficiency.
amp deaminase deficiency
Gene mutations responsible for human erythrocyte AMP deaminase deficiency in Poles.
amp deaminase deficiency
Genetic characteristics of myoadenylate deaminase deficiency.
amp deaminase deficiency
Genetic risk factors associated with lipid-lowering drug-induced myopathies.
amp deaminase deficiency
Human myoadenylate deaminase deficiency.
amp deaminase deficiency
Immunohistochemical analysis of human skeletal muscle AMP deaminase deficiency. Evidence of a correlation between the muscle HPRG content and the level of the residual AMP deaminase activity.
amp deaminase deficiency
Immunolocalization of AMP-deaminase isozymes in human skeletal muscle and cultured muscle cells: concentration of isoform M at the neuromuscular junction.
amp deaminase deficiency
Immunologic distinction of human muscle adenylate deaminase from the isoenzyme(s) in human peripheral blood cells: implications for myoadenylate deaminase deficiency.
amp deaminase deficiency
Improvement of screening in exertional myalgia with a standardized ischemic forearm test.
amp deaminase deficiency
Influence on myoadenylate deaminase function in rat skeletal muscle after homologous and heterologous immunization with the purified enzyme.
amp deaminase deficiency
Ischaemic exercise test in myoadenylate deaminase deficiency and McArdle's disease: measurement of plasma adenosine, inosine and hypoxanthine.
amp deaminase deficiency
Isozymes of AMP-Deaminase in Muscles Myasthenia Gravis Patients.
amp deaminase deficiency
Kinetic and immunologic evidence for a complete gene block in myoadenylate deaminase deficiency.
amp deaminase deficiency
Levels of adenylate deaminase, adenylate kinase, and creatine kinase in frozen human muscle biopsy specimens relative to type 1/type 2 fiber distribution: evidence for a carrier state of myoadenylate deaminase deficiency.
amp deaminase deficiency
McArdle's disease with myoadenylate deaminase deficiency: observations in a combined enzyme deficiency.
amp deaminase deficiency
Medical implications of the lactate and ammonia relationship in anaerobic exercise.
amp deaminase deficiency
Metabolic myopathies.
amp deaminase deficiency
Metabolism of D-ribose administered continuously to healthy persons and to patients with myoadenylate deaminase deficiency.
amp deaminase deficiency
Mild myopathic phenotype in a patient with homozygous c.416C > T mutation in TK2 gene.
amp deaminase deficiency
Molecular analysis of acquired myoadenylate deaminase deficiency in polymyositis (idiopathic inflammatory myopathy).
amp deaminase deficiency
Molecular analysis of Spanish patients with AMP deaminase deficiency.
amp deaminase deficiency
Molecular analysis of the myoadenylate deaminase deficiencies.
amp deaminase deficiency
Molecular basis for human erythrocyte AMP deaminase deficiency: screening for the major point mutation and identification of other mutations.
amp deaminase deficiency
Molecular basis of AMP deaminase deficiency in skeletal muscle.
amp deaminase deficiency
Molecular biology of AMP deaminase deficiency.
amp deaminase deficiency
Muscle adenylate deaminase deficiency. Report of six new cases.
amp deaminase deficiency
Muscle AMP deaminase deficiency in 2% of a healthy population.
amp deaminase deficiency
Mutant carnitine palmitoyltransferase associated with myoadenylate deaminase deficiency in skeletal muscle.
amp deaminase deficiency
Myoadenylate deaminase deficiency and forearm ischemic exercise testing.
amp deaminase deficiency
Myoadenylate deaminase deficiency and malignant hyperthermia susceptibility: is there a relationship?
amp deaminase deficiency
Myoadenylate deaminase deficiency caused by alternative splicing due to a novel intronic mutation in the AMPD1 gene.
amp deaminase deficiency
Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans.
amp deaminase deficiency
Myoadenylate deaminase deficiency in a 5-year-old boy with intermittent muscle pain.
amp deaminase deficiency
Myoadenylate deaminase deficiency in a patient with facial and limb girdle myopathy.
amp deaminase deficiency
Myoadenylate deaminase deficiency in a patient with progressive systemic sclerosis.
amp deaminase deficiency
Myoadenylate deaminase deficiency in children.
amp deaminase deficiency
Myoadenylate deaminase deficiency in twins with recessive olivopontocerebellar atrophy.
amp deaminase deficiency
Myoadenylate deaminase deficiency myopathy in pregnancy.
amp deaminase deficiency
Myoadenylate deaminase deficiency or not? Observations on two brothers with exercise-induced muscle pain.
amp deaminase deficiency
Myoadenylate deaminase deficiency studies on normal and deaminase-deficient skeletal muscle.
amp deaminase deficiency
Myoadenylate deaminase deficiency with progressive muscle weakness and atrophy caused by new missense mutations in AMPD1 gene: case report in a Japanese patient.
amp deaminase deficiency
Myoadenylate deaminase deficiency with severe rhabdomyolysis.
amp deaminase deficiency
Myoadenylate deaminase deficiency, hypertrophic cardiomyopathy and gigantism syndrome.
amp deaminase deficiency
Myoadenylate deaminase deficiency.
amp deaminase deficiency
Myoadenylate deaminase deficiency. A common inherited defect with heterogeneous clinical presentation.
amp deaminase deficiency
Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle.
amp deaminase deficiency
Myoadenylate deaminase deficiency: a clinical, genetic, and biochemical study in nine families.
amp deaminase deficiency
Myoadenylate deaminase deficiency: a frequent cause of muscle pain A case detected by exercise testing.
amp deaminase deficiency
Myoadenylate deaminase deficiency: a new disease of muscle.
amp deaminase deficiency
Myoadenylate deaminase deficiency: absence of correlation with exercise intolerance in 452 muscle biopsies.
amp deaminase deficiency
Myoadenylate deaminase deficiency: an enzyme defect in search of a disease.
amp deaminase deficiency
Myoadenylate deaminase deficiency: clinico-pathological and molecular study of a series of 27 Spanish cases.
amp deaminase deficiency
Myoadenylate deaminase deficiency: diagnosis by forearm ischemic exercise testing.
amp deaminase deficiency
Myoadenylate deaminase deficiency: fact and fancy.
amp deaminase deficiency
Myoadenylate deaminase deficiency: inherited and acquired forms.
amp deaminase deficiency
Myoadenylate deaminase deficiency: primary and secondary types.
amp deaminase deficiency
Myoadenylate deaminase deficiency: successful symptomatic therapy by high dose oral administration of ribose.
amp deaminase deficiency
Myogenic hyperuricemia: what can we learn from metabolic myopathies?
amp deaminase deficiency
Myotonia congenita and myoadenylate deaminase deficiency: case report.
amp deaminase deficiency
New method for detection of C34-T mutation in the AMPD1 gene causing myoadenylate deaminase deficiency.
amp deaminase deficiency
Peripartum anaesthetic management of a patient with Brugada syndrome and myoadenylate deaminase deficiency.
amp deaminase deficiency
Positive malignant hyperthermia susceptibility in vitro test in a patient with mitochondrial myopathy and myoadenylate deaminase deficiency.
amp deaminase deficiency
Primary Adenosine Monophosphate Deaminase Deficiency in a Hypotonic Infant.
amp deaminase deficiency
Primary, secondary, and coincidental types of myoadenylate deaminase deficiency.
amp deaminase deficiency
Progressive myalgias and polyarthralgias in a patient with myoadenylate deaminase deficiency.
amp deaminase deficiency
Proteinuria in AMPD2-deficient mice.
amp deaminase deficiency
Rapid determination of the hypoxanthine increase in ischemic exercise tests.
amp deaminase deficiency
Rhabdomyolysis associated with malaria tertiana in a patient with myoadenylate deaminase deficiency.
amp deaminase deficiency
Ribose administration during exercise: effects on substrates and products of energy metabolism in healthy subjects and a patient with myoadenylate deaminase deficiency.
amp deaminase deficiency
Right ventricular obstructive hypertrophic cardiomyopathy in primary myo-adenylate deaminase deficiency.
amp deaminase deficiency
Skeletal muscle adenosine, inosine and hypoxanthine release following ischaemic forearm exercise in myoadenylate deaminase deficiency and McArdle's disease.
amp deaminase deficiency
Stain for skeletal muscle adenylate deaminase. An effective tetrazolium stain for frozen biopsy specimens.
amp deaminase deficiency
Tension myalgia versus myoadenylate deaminase deficiency: a case report.
amp deaminase deficiency
The exercise metaboreflex is maintained in the absence of muscle acidosis: insights from muscle microdialysis in humans with McArdle's disease.
amp deaminase deficiency
The genetic basis of myoadenylate deaminase deficiency is heterogeneous.
amp deaminase deficiency
The molecular basis of skeletal muscle weakness in a mouse model of inflammatory myopathy.
amp deaminase deficiency
The oxidative pentose phosphate pathway in the heart: regulation, physiological significance, and clinical implications.
amp deaminase deficiency
The purine nucleotide cycle and its molecular defects.
amp deaminase deficiency
The ratio of maximal handgrip force and maximal cycloergometry power as a diagnostic tool to screen for metabolic myopathies.
amp deaminase deficiency
Type 2a fibre rhabdomyolysis in myoadenylate deaminase deficiency.
amp deaminase deficiency
Use of dynamic tests of muscle function and histomorphometry of quadriceps muscle biopsies in the investigation of patients with chronic alcohol misuse and chronic fatigue syndrome.
amp deaminase deficiency
What can metabolic myopathies teach us about exercise physiology?
amp deaminase deficiency
[A 22-year-old man with long-standing weakness and atrophy predominantly in the lower extremities]
amp deaminase deficiency
[AMP deaminase deficiency (myoadenylate deaminase). Disease or syndrome?]
amp deaminase deficiency
[AMP deaminase deficiency]
amp deaminase deficiency
[AMPD genes and urate metabolism]
amp deaminase deficiency
[Diagnostic significance of muscle biopsies in metabolic myopathies. II. Clinical biochemistry]
amp deaminase deficiency
[McArdle's disease]
amp deaminase deficiency
[Metabolic intolerance to exercise]
amp deaminase deficiency
[Muscle AMP deaminase deficiency]
amp deaminase deficiency
[Muscle weakness and CK elevation: is it myositis?]
amp deaminase deficiency
[Muscular intolerance of exercise. Current data]
amp deaminase deficiency
[Myoadenylate deaminase deficiency among patients with myasthenia gravis--preliminary results of exercise]
amp deaminase deficiency
[Myoadenylate deaminase deficiency in a child with myalgias induced by physical exercise]
amp deaminase deficiency
[Myoadenylate deaminase deficiency]
amp deaminase deficiency
[Myopathy in AMP deaminase deficiency]
Amyotrophic Lateral Sclerosis
Metabolic Aspects of Adenosine Functions in the Brain.
Anemia
AMPD3-deficient mice exhibit increased erythrocyte ATP levels but anemia not improved due to PK deficiency.
Anemia
Effect of adenosine monophosphate deaminase-1 C34T allele on the requirement for donor inotropic support and on the incidence of early graft dysfunction after cardiac transplantation.
Anemia
Erythrocyte membrane associated enzymes of hemolytic anemias: ATPases, AMP deaminase and GAPD.
Anemia, Hemolytic
AMPD3-deficient mice exhibit increased erythrocyte ATP levels but anemia not improved due to PK deficiency.
Anemia, Sickle Cell
Ca2+-CaM activation of AMP deaminase contributes to adenine nucleotide dysregulation and phosphatidylserine externalization in human sickle erythrocytes.
Anthrax
AMPD3 is involved in anthrax LeTx-induced macrophage cell death.
Arthralgia
Progressive myalgias and polyarthralgias in a patient with myoadenylate deaminase deficiency.
Arthritis, Rheumatoid
Effect of the 34C>T variant in the AMPD1 gene on the clinical response to methotrexate in patients with rheumatoid arthritis: comment on the article by Wessels et al.
Arthritis, Rheumatoid
Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients.
Asthma
[The effect of aminophylline on plasma oxypurines in patients with bronchial asthma or cor pulmonale]
Atherosclerosis
Association between AMPD1 gene polymorphism and coagulation factors in patients with coronary heart disease.
Autoimmune Diseases
Treatment of experimental autoimmune encephalomyelitis with adenylate deaminase from Penicillium lanoso-viride.
Barth Syndrome
Cardiac involvement in primary myopathies.
Brugada Syndrome
Peripartum anaesthetic management of a patient with Brugada syndrome and myoadenylate deaminase deficiency.
Carcinogenesis
CHANGES IN THE ADENYLIC ACID DEAMINASE ACTIVITY OF RAT LIVER DURING CARCINOGENESIS.
Carcinogenesis
[Influence of thymostimulin on the activity of certain enzymes of adenosine and AMP metabolism in lymphocytes of rats with mammary cancer]
Carcinoma
Comparative immunologic and kinetic evaluation of AMP-deaminase isolated from normal human liver and hepatocellular carcinoma (HCC).
Carcinoma
Studies on purine enzymes in experimental colitis.
Carcinoma, Ehrlich Tumor
Role of the adenylate deaminase reaction in regulation of adenine nucleotide metabolism in Ehrlich ascites tumor cells.
Carcinoma, Ehrlich Tumor
[Application of tiazofurin in the study of regulation of AMP deaminase in intact malignant cells]
Carcinoma, Hepatocellular
Comparative immunologic and kinetic evaluation of AMP-deaminase isolated from normal human liver and hepatocellular carcinoma (HCC).
Carcinoma, Hepatocellular
Enzymes of purine metabolism in cancer.
Carcinoma, Hepatocellular
Expression patterns of AMP-deaminase isozymes in human hepatocellular carcinoma (HCC).
Cardiomegaly
Association between AMPD1 gene polymorphism and coagulation factors in patients with coronary heart disease.
Cardiomyopathy, Dilated
Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome).
Cardiomyopathy, Hypertrophic
Myoadenylate deaminase deficiency, hypertrophic cardiomyopathy and gigantism syndrome.
Cardiovascular Diseases
AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases.
Cardiovascular Diseases
Association of C34T AMPD1 gene polymorphism with features of metabolic syndrome in patients with coronary artery disease or heart failure.
Cardiovascular Diseases
Effects of AMPD1 gene C34T polymorphism on cardiac index, blood pressure and prognosis in patients with cardiovascular diseases: a meta-analysis.
Chemical and Drug Induced Liver Injury
AMP deaminase and adenosine deaminase activities in liver and brain regions in acute ammonia intoxication and subacute toxic hepatitis.
Colitis
Blood purine and energy status in rats with colitis.
Colonic Neoplasms
Gene expression profiling following constitutive activation of MEK1 and transformation of rat intestinal epithelial cells.
Colonic Neoplasms
High expression of AMPD2 and obesity are associated with poor prognosis in colorectal cancer.
Colorectal Neoplasms
High expression of AMPD2 and obesity are associated with poor prognosis in colorectal cancer.
Colorectal Neoplasms
Overexpression of AMPD2 indicates poor prognosis in colorectal cancer patients via the Notch3 signaling pathway.
Colorectal Neoplasms
Ten recently identified associations between nsSNPs and colorectal cancer could not be replicated in German families.
Contracture
Myoadenylate deaminase deficiency and malignant hyperthermia susceptibility: is there a relationship?
Coronary Artery Disease
A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease.
Coronary Artery Disease
AMPD1 (C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization.
Coronary Artery Disease
AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases.
Coronary Artery Disease
Association of C34T AMPD1 gene polymorphism with features of metabolic syndrome in patients with coronary artery disease or heart failure.
Coronary Artery Disease
Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients.
Coronary Artery Disease
Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome).
Coronary Artery Disease
The impact of AMPD1 gene polymorphism on vascular function and inflammation in patients with coronary artery disease.
Coronary Disease
Association between AMPD1 gene polymorphism and coagulation factors in patients with coronary heart disease.
creatine kinase deficiency
Alterations in AMP deaminase activity and kinetics in skeletal muscle of creatine kinase-deficient mice.
Crohn Disease
New bioinformatics approach to analyze gene expressions and signaling pathways reveals unique purine gene dysregulation profiles that distinguish between CD and UC.
Crush Syndrome
Activity of enzymes of adenyline compounds metabolism during crush and decompression of muscle tissue. Part I. Adenylate deaminase activity at experimental crush syndrome.
Cysts
Super-enhancer-driven metabolic reprogramming promotes cystogenesis in autosomal dominant polycystic kidney disease.
Diabetes Mellitus, Type 2
Xanthine oxidoreductase-mediated injury is amplified by upregulated AMP deaminase in type 2 diabetic rat hearts under the condition of pressure overload.
Disorders of Excessive Somnolence
Hypersomnia with dilated pupils in adenosine monophosphate deaminase (AMPD) deficiency.
Distal Myopathies
High AMP deaminase activity in rimmed vacuoles of skeletal muscle.
Distal Myopathies
Immunohistochemical localization of AMP deaminase in rimmed vacuoles in human skeletal muscle.
Encephalomyelitis
Treatment of experimental autoimmune encephalomyelitis with adenylate deaminase from Penicillium lanoso-viride.
Encephalomyelitis, Autoimmune, Experimental
Treatment of experimental autoimmune encephalomyelitis with adenylate deaminase from Penicillium lanoso-viride.
Endotoxemia
Circulating adenosine increases during human experimental endotoxemia but blockade of its receptor does not influence the immune response and subsequent organ injury.
Epilepsy
Metabolic Aspects of Adenosine Functions in the Brain.
Essential Hypertension
Association between the C34T polymorphism of the AMPD1 gene and essential hypertension in Malaysian patients.
Essential Hypertension
[Value of oxypurines and uric acid in plasma, renal excretion of oxypurines and uric acid as well as plasma adenosine deaminase and AMP deaminase activity in patients with essential hypertension]
Fatigue Syndrome, Chronic
Genetic evaluation of AMPD1, CPT2, and PGYM metabolic enzymes in patients with chronic fatigue syndrome.
Fatty Liver
Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver.
Fibromyalgia
Tension myalgia versus myoadenylate deaminase deficiency: a case report.
Gastrointestinal Stromal Tumors
AMPD3 is associated with the malignant characteristics of gastrointestinal stromal tumors.
Genetic Diseases, Inborn
The effect of AMPD1 genotype on blood flow response to sprint exercise.
Gigantism
Myoadenylate deaminase deficiency, hypertrophic cardiomyopathy and gigantism syndrome.
glucan 1,4-alpha-glucosidase deficiency
High AMP deaminase activity in rimmed vacuoles of skeletal muscle.
glucan 1,4-alpha-glucosidase deficiency
Immunohistochemical localization of AMP deaminase in rimmed vacuoles in human skeletal muscle.
Glucose Intolerance
A novel method for testing association of multiple genetic markers with a multinomial trait.
Glucose Intolerance
Role of AMPD2 in impaired glucose tolerance induced by high fructose diet.
glycogen phosphorylase deficiency
McArdle's disease with myoadenylate deaminase deficiency: observations in a combined enzyme deficiency.
glycogen phosphorylase deficiency
Phenotype modulators in myophosphorylase deficiency.
Glycogen Storage Disease
Cardiac involvement in primary myopathies.
Glycogen Storage Disease
Diagnostic Algorithm for Glycogenoses and Myoadenylate Deaminase Deficiency Based on Exercise Testing Parameters: A Prospective Study.
Glycogen Storage Disease
Diagnostic utility of a modified forearm ischemic exercise test and technical issues relevant to exercise testing.
Glycogen Storage Disease
Exercise efficiency impairment in metabolic myopathies.
Glycogen Storage Disease
Metabolic myopathies.
Glycogen Storage Disease
Metabolic myopathies: update 2009.
Glycogen Storage Disease
Rapid determination of the hypoxanthine increase in ischemic exercise tests.
Glycogen Storage Disease Type II
Cardiac involvement in primary myopathies.
Glycogen Storage Disease Type II
High AMP deaminase activity in rimmed vacuoles of skeletal muscle.
Glycogen Storage Disease Type II
Immunohistochemical localization of AMP deaminase in rimmed vacuoles in human skeletal muscle.
Glycogen Storage Disease Type V
Does the K153R variant of the myostatin gene influence the clinical presentation of women with McArdle disease?
Glycogen Storage Disease Type V
Double trouble: combined myophosphorylase and AMP deaminase deficiency in a child homozygous for nonsense mutations at both loci.
Glycogen Storage Disease Type V
Exercise testing-based algorithms to diagnose McArdle disease and MAD defects.
Glycogen Storage Disease Type V
Exertional rhabdomyolysis: a clinical review with a focus on genetic influences.
Glycogen Storage Disease Type V
Ischaemic exercise test in myoadenylate deaminase deficiency and McArdle's disease: measurement of plasma adenosine, inosine and hypoxanthine.
Glycogen Storage Disease Type V
McArdle disease causing rhabdomyolysis following vaginal delivery.
Glycogen Storage Disease Type V
McArdle's disease with myoadenylate deaminase deficiency: observations in a combined enzyme deficiency.
Glycogen Storage Disease Type V
Normal activities of AMP-deaminase and adenylate kinase in patients with McArdle disease.
Glycogen Storage Disease Type V
Phenotype modulators in myophosphorylase deficiency.
Glycogen Storage Disease Type V
Skeletal muscle adenosine, inosine and hypoxanthine release following ischaemic forearm exercise in myoadenylate deaminase deficiency and McArdle's disease.
Glycogen Storage Disease Type V
The oxidative pentose phosphate pathway in the heart: regulation, physiological significance, and clinical implications.
Glycogen Storage Disease Type V
[McArdle's disease]
Glycogen Storage Disease Type VII
Calcium activates erythrocyte AMP deaminase [isoform E (AMPD3)] through a protein-protein interaction between calmodulin and the N-terminal domain of the AMPD3 polypeptide.
Gout
Abnormal AMP deaminase in primary gout.
Gout
Myoadenylate deaminase deficiency--muscle biopsy and muscle culture in a patient with gout.
Heart Diseases
A G468-T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population.
Heart Diseases
Biological efficiency of AMP deaminase inhibitor: 3-[2-(3-carboxy-4-bromo-5,6,7,8-tetrahydronaphthyl)ethyl]-3,6,7,8-tetrahydroimidazo[4,5]-[1,3]diazepin-8-OL.
Heart Diseases
Cardiac muscle AMP-deaminase from a 10-year-old male heterozygous for the AMPD1 C34T mutation.
Heart Diseases
Effect of AMP-deaminase 3 knock-out in mice on enzyme activity in heart and other organs.
Heart Diseases
Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients.
Heart Diseases
Modulation of AMP deaminase in rat hearts subjected to ischemia and reperfusion by purine riboside.
Heart Diseases
Pharmacological inhibition of AMP-deaminase in rat cardiac myocytes.
Heart Diseases
Protection of mouse heart against hypoxic damage by AMP deaminase inhibition.
Heart Failure
A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease.
Heart Failure
A common variant of the AMPD1 gene predicts improved survival in patients with ischemic left ventricular dysfunction.
Heart Failure
A polymorphism of the gene encoding AMPD1: clinical impact and proposed mechanisms in congestive heart failure.
Heart Failure
Adenosine and cardioprotection: what can we learn from nature's genetic polymorphism?
Heart Failure
AMP Deaminase 1 Gene Polymorphism and Heart Disease-A Genetic Association That Highlights New Treatment.
Heart Failure
AMPD1 (C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization.
Heart Failure
AMPD1 gene mutation in congestive heart failure: new insights into the pathobiology of disease progression.
Heart Failure
AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases.
Heart Failure
AMPD1 gene polymorphism and survival in patients with stable congestive heart failure.
Heart Failure
Association of C34T AMPD1 gene polymorphism with features of metabolic syndrome in patients with coronary artery disease or heart failure.
Heart Failure
Association of improved cardiac function in donors with C34T mutation of the AMP deaminase 1 gene.
Heart Failure
C34T AMP deaminase 1 gene mutation protects cardiac function in donors.
Heart Failure
Cardiac muscle AMP-deaminase from a 10-year-old male heterozygous for the AMPD1 C34T mutation.
Heart Failure
Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure.
Heart Failure
Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation--a potential mechanism of protection in heart failure.
Heart Failure
Effects of AMPD1 common mutation on the metabolic-chronotropic relationship: Insights from patients with myoadenylate deaminase deficiency.
Heart Failure
Effects of AMPD1 gene C34T polymorphism on cardiac index, blood pressure and prognosis in patients with cardiovascular diseases: a meta-analysis.
Heart Failure
Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients.
Heart Failure
Metalloproteinase inhibitor counters high-energy phosphate depletion and AMP deaminase activity enhancing ventricular diastolic compliance in subacute heart failure.
Heart Failure
Positive and negative elements mediate control of alternative splicing in the AMPD1 gene.
Heart Failure
Protection of mouse heart against hypoxic damage by AMP deaminase inhibition.
Heart Failure
Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome).
Heart Failure
Shortage of Cellular ATP as a Cause of Diseases and Strategies to Enhance ATP.
Heart Failure
The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure. A study on 686 consecutive patients.
Heart Failure
The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patients.
Heart Failure
The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failure.
Hepatitis
Activation of AMP deaminase and adenosine deaminase in the liver during ammonia poisoning and hepatitis.
Hepatitis
AMP deaminase and adenosine deaminase activities in liver and brain regions in acute ammonia intoxication and subacute toxic hepatitis.
Huntington Disease
Metabolic Aspects of Adenosine Functions in the Brain.
Hypercholesterolemia
A mutation in Ampd2 is associated with nephrotic syndrome and hypercholesterolemia in mice.
Infections
Antischistosomal and liver protective effects of Curcuma longa extract in Schistosoma mansoni infected mice.
Infections
Biochemical genetic analysis of 2',3'-dideoxyadenosine metabolism in human T lymphocytes.
Infections
Effects of the 34C>T Variant of the AMPD1 Gene on Immune Function, Multi-Organ Dysfunction, and Mortality in Sepsis Patients.
Infections
Protective effect of adenylate deaminase (from Penicillium lanoso-viride) against acute infections in mice.
Infections
Severe rhabdomyolysis caused by Plasmodium vivax malaria in the Brazilian Amazon.
Inflammatory Bowel Diseases
Studies on purine enzymes in experimental colitis.
Influenza, Human
Protective effect of adenylate deaminase (from Penicillium lanoso-viride) against acute infections in mice.
Insulin Resistance
AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle.
Insulin Resistance
AMPD1: a novel therapeutic target for reversing insulin resistance.
Insulin Resistance
Erratum to: AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle.
Insulin Resistance
Inhibition of AMP deaminase activity does not improve glucose control in rodent models of insulin resistance or diabetes.
Kidney Failure, Chronic
Degradation of adenine nucleotides in the erythrocytes of patients with chronic renal failure.
Leigh Disease
Diagnosis and treatment in a case of juvenile subacute necrotizing encephalopathy Leigh without cytochrome c oxidase deficiency.
Leukemia, Lymphocytic, Chronic, B-Cell
Enzymological studies in chronic lymphocytic leukemia.
Liver Failure
Activation of AMP deaminase and adenosine deaminase in the liver during ammonia poisoning and hepatitis.
Lung Injury
AMP deaminase 3 plays a critical role in remote reperfusion lung injury.
Lung Injury
Remote reperfusion lung injury is associated with AMP deaminase 3 activation and attenuated by inosine monophosphate.
Lupus Erythematosus, Systemic
NovelmiRNA-25 inhibits AMPD2 in peripheral blood mononuclear cells of patients with systemic lupus erythematosus and represents a promising novel biomarker.
Lymphatic Metastasis
Expression of serum AMPD1 in thyroid carcinoma and its clinical significance.
Lymphoma
Adenylate deaminase deficiency in a mutant murine T cell lymphoma cell line.
Lymphoma
Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
Lymphoma, T-Cell
Adenylate deaminase deficiency in a mutant murine T cell lymphoma cell line.
Malaria
Adenosine monophosphate deaminase 3 activation shortens erythrocyte half-life and provides malaria resistance in mice.
Malaria
Rhabdomyolysis associated with malaria tertiana in a patient with myoadenylate deaminase deficiency.
Malaria
Severe rhabdomyolysis caused by Plasmodium vivax malaria in the Brazilian Amazon.
Malaria
The deamination of adenosine and adenosine monophosphate in Plasmodium falciparum-infected human erythrocytes: in vitro use of 2'deoxycoformycin and AMP deaminase-deficient red cells.
Malaria, Falciparum
Severe rhabdomyolysis caused by Plasmodium vivax malaria in the Brazilian Amazon.
Malnutrition
Effect of undernutrition on some enzymes of purine metabolism in different regions of developing rat brain.
Melanoma
Nucleotide-metabolism and chromosome alterations in human-malignant melanoma xenografts.
Metabolic Diseases
Molecular analysis of Spanish patients with AMP deaminase deficiency.
Metabolic Diseases
Myoadenylate deaminase deficiency. A common inherited defect with heterogeneous clinical presentation.
Metabolic Syndrome
Association of C34T AMPD1 gene polymorphism with features of metabolic syndrome in patients with coronary artery disease or heart failure.
Metabolic Syndrome
Gout and Metabolic Syndrome: a Tangled Web.
Microcephaly
Clinical and genetic spectrum of AMPD2-related pontocerebellar hypoplasia type 9.
Mitochondrial Diseases
Diagnostic utility of a modified forearm ischemic exercise test and technical issues relevant to exercise testing.
Mitochondrial Diseases
Exercise efficiency impairment in metabolic myopathies.
Mitochondrial Diseases
The ratio of maximal handgrip force and maximal cycloergometry power as a diagnostic tool to screen for metabolic myopathies.
Mitochondrial Myopathies
Metabolic myopathies: update 2009.
Mitochondrial Myopathies
Positive malignant hyperthermia susceptibility in vitro test in a patient with mitochondrial myopathy and myoadenylate deaminase deficiency.
Muscle Cramp
Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency.
Muscle Cramp
Cramps, spasms and muscle stiffness.
Muscle Cramp
Enzymes of the purine nucleotide cycle in muscle of patients with exercise intolerance.
Muscle Cramp
Metabolic myopathies.
Muscle Cramp
Myoadenylate deaminase deficiency and forearm ischemic exercise testing.
Muscle Cramp
Myoadenylate deaminase deficiency caused by alternative splicing due to a novel intronic mutation in the AMPD1 gene.
Muscle Cramp
Myoadenylate deaminase deficiency--muscle biopsy and muscle culture in a patient with gout.
Muscle Cramp
Myoadenylate deaminase deficiency.
Muscle Cramp
[Myoadenylate deaminase deficiency in a child with myalgias induced by physical exercise]
Muscle Hypotonia
Primary Adenosine Monophosphate Deaminase Deficiency in a Hypotonic Infant.
Muscle Neoplasms
AMP-deaminase from human uterine muscle neoplasm (leiomyoma).
Muscle Weakness
Daily supplementation of D-ribose shows no therapeutic benefits in the MHC-I transgenic mouse model of inflammatory myositis.
Muscle Weakness
Myoadenylate deaminase deficiency with progressive muscle weakness and atrophy caused by new missense mutations in AMPD1 gene: case report in a Japanese patient.
Muscle Weakness
Myoadenylate deaminase deficiency.
Muscle Weakness
Primary Adenosine Monophosphate Deaminase Deficiency in a Hypotonic Infant.
Muscle Weakness
The molecular basis of skeletal muscle weakness in a mouse model of inflammatory myopathy.
Muscular Atrophy
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression.
Muscular Diseases
A G468-T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population.
Muscular Diseases
Acute myopathy associated with chronic licorice ingestion: reversible loss of myoadenylate deaminase activity.
Muscular Diseases
Alternative splicing: a mechanism for phenotypic rescue of a common inherited defect.
Muscular Diseases
Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency.
Muscular Diseases
Clinical significance and neuropathology of primary MADD in C34-T and G468-T mutations of the AMPD1 gene.
Muscular Diseases
Clinical use of creatine in neuromuscular and neurometabolic disorders.
Muscular Diseases
First missense mutations (R388W and R425H) of AMPD1 accompanied with myopathy found in a Japanese patient.
Muscular Diseases
Functionally distinct elements are required for expression of the AMPD1 gene in myocytes.
Muscular Diseases
High AMP deaminase activity in rimmed vacuoles of skeletal muscle.
Muscular Diseases
Metabolic myopathies: update 2009.
Muscular Diseases
Molecular analysis of the myoadenylate deaminase deficiencies.
Muscular Diseases
Mutation and biochemical analysis in carnitine palmitoyltransferase type II (CPT II) deficiency.
Muscular Diseases
Myoadenylate deaminase deficiency in a patient with facial and limb girdle myopathy.
Muscular Diseases
Myoadenylate deaminase deficiency myopathy in pregnancy.
Muscular Diseases
Myoadenylate deaminase deficiency: a frequent cause of muscle pain A case detected by exercise testing.
Muscular Diseases
Myoadenylate deaminase deficiency: clinico-pathological and molecular study of a series of 27 Spanish cases.
Muscular Diseases
Peripartum anaesthetic management of a patient with Brugada syndrome and myoadenylate deaminase deficiency.
Muscular Diseases
Regulation of skeletal muscle ATP catabolism by AMPD1 genotype during sprint exercise in asymptomatic subjects.
Muscular Diseases
Sensitive, optimized assay for serum AMP deaminase.
Muscular Diseases
The ratio of maximal handgrip force and maximal cycloergometry power as a diagnostic tool to screen for metabolic myopathies.
Muscular Diseases
[AMP-aminohydrolase of skeletal muscles in muscular diseases]
Muscular Diseases
[AMPD genes and urate metabolism]
Muscular Diseases
[Biochemical studies on muscle disorder. Change of the activity of AMP-deaminase in skeletal muscle and the activity of adenosine-deaminase in serum.]
Muscular Diseases
[Genetic marker of statin-induced rhabdomyolysis].
Muscular Diseases
[McArdle's disease]
Muscular Diseases
[Metabolic intolerance to exercise]
Muscular Diseases
[Muscular intolerance of exercise. Current data]
Muscular Diseases
[Myopathy in AMP deaminase deficiency]
Muscular Dystrophies
AMP deaminase activity of skeletal muscle in neuromuscular disorders in childhood. Histochemical and biochemical studies.
Muscular Dystrophies
Muscle adenylic acid deaminase activity. Selective decrease in early-onset Duchenne muscular dystrophy.
Muscular Dystrophy, Duchenne
Cardiac involvement in primary myopathies.
Muscular Dystrophy, Duchenne
Muscle adenylic acid deaminase activity. Selective decrease in early-onset Duchenne muscular dystrophy.
Myalgia
A G468-T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population.
Myalgia
Chronic non-exertional myalgia and myoadenylate deaminase deficiency: a possible association.
Myalgia
Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency.
Myalgia
Daily supplementation of D-ribose shows no therapeutic benefits in the MHC-I transgenic mouse model of inflammatory myositis.
Myalgia
Familial myoadenylate deaminase deficiency and exertional myalgia.
Myalgia
Myalgia with partial defects of mitochondrial enzyme and myoadenylate deaminase.
Myalgia
Myoadenylate deaminase deficiency in a 5-year-old boy with intermittent muscle pain.
Myalgia
Myoadenylate deaminase deficiency or not? Observations on two brothers with exercise-induced muscle pain.
Myalgia
Myoadenylate deaminase deficiency--muscle biopsy and muscle culture in a patient with gout.
Myalgia
Myoadenylate deaminase deficiency: a frequent cause of muscle pain A case detected by exercise testing.
Myalgia
Myoadenylate deaminase deficiency: successful symptomatic therapy by high dose oral administration of ribose.
Myalgia
Myoadenylate-deaminase gene mutation associated with left ventricular hypertrabeculation/non-compaction.
Myalgia
Myotonia congenita and myoadenylate deaminase deficiency: case report.
Myalgia
Tension myalgia versus myoadenylate deaminase deficiency: a case report.
Myalgia
The ratio of maximal handgrip force and maximal cycloergometry power as a diagnostic tool to screen for metabolic myopathies.
Myasthenia Gravis
AMP-Deaminase from Thymus of Patients with Myasthenia Gravis.
Myasthenia Gravis
Isozymes of AMP-Deaminase in Muscles Myasthenia Gravis Patients.
Myocardial Infarction
AMP deaminase, 5'-nucleotidase and adenosine deaminase in rat myocardial tissue in myocardial infarction and hypothermia.
Myocardial Infarction
Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients.
Myocardial Infarction
Stimulation of DNA synthesis and AMP deaminase activity in rat hearts during isoproterenol-induced myocardial infarction.
Myocardial Ischemia
Adenosine and cardioprotection: what can we learn from nature's genetic polymorphism?
Myocardial Ischemia
AMP Deaminase 1 Gene Polymorphism and Heart Disease-A Genetic Association That Highlights New Treatment.
Myocardial Ischemia
Association of improved cardiac function in donors with C34T mutation of the AMP deaminase 1 gene.
Myocardial Ischemia
Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation--a potential mechanism of protection in heart failure.
Myocardial Ischemia
Protection of mouse heart against hypoxic damage by AMP deaminase inhibition.
Myoglobinuria
Combined defects of muscle phosphofructokinase and AMP deaminase in a child with myoglobinuria.
Myoglobinuria
Metabolic causes of myoglobinuria.
Myoglobinuria
Metabolic myopathies.
Myopathies, Structural, Congenital
Cardiac involvement in primary myopathies.
Myopathy, Central Core
Cardiac involvement in primary myopathies.
Myositis
Clinical use of creatine in neuromuscular and neurometabolic disorders.
Myositis
Daily supplementation of D-ribose shows no therapeutic benefits in the MHC-I transgenic mouse model of inflammatory myositis.
Myositis
Muscle biopsy features in critical ill patients with 2009 influenza A (H1N1) virus infection.
Myositis
The molecular basis of skeletal muscle weakness in a mouse model of inflammatory myopathy.
Myotonia Congenita
Myotonia congenita and myoadenylate deaminase deficiency: case report.
Myotonic Dystrophy
Cardiac involvement in primary myopathies.
Neoplasm Metastasis
Expression of serum AMPD1 in thyroid carcinoma and its clinical significance.
Neoplasms
Adenosine deaminase and AMP deaminase activities in blood of cancer patients.
Neoplasms
Adenylic acid deaminase activity in spectrum of rat tumors and in normal liver.
Neoplasms
AMPD3 is associated with the malignant characteristics of gastrointestinal stromal tumors.
Neoplasms
Biomarkers Associated with Tumor Heterogeneity in Prostate Cancer.
Neoplasms
Characterizing and optimizing human anticancer drug targets based on topological properties in the context of biological pathways.
Neoplasms
Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations.
Neoplasms
Expression of serum AMPD1 in thyroid carcinoma and its clinical significance.
Neoplasms
Gene expression profiling following constitutive activation of MEK1 and transformation of rat intestinal epithelial cells.
Neoplasms
High expression of AMPD2 and obesity are associated with poor prognosis in colorectal cancer.
Neoplasms
Overexpression of AMPD2 indicates poor prognosis in colorectal cancer patients via the Notch3 signaling pathway.
Neoplasms
Remote reperfusion lung injury is associated with AMP deaminase 3 activation and attenuated by inosine monophosphate.
Neoplasms
Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome).
Neoplasms
Role of the adenylate deaminase reaction in regulation of adenine nucleotide metabolism in Ehrlich ascites tumor cells.
Neoplasms
[Application of tiazofurin in the study of regulation of AMP deaminase in intact malignant cells]
Nephrotic Syndrome
A mutation in Ampd2 is associated with nephrotic syndrome and hypercholesterolemia in mice.
Neurodegenerative Diseases
Metabolic Aspects of Adenosine Functions in the Brain.
Neurodegenerative Diseases
Neuroradiological findings in three cases of pontocerebellar hypoplasia type 9 due to AMPD2 mutation: typical MRI appearances and pearls for differential diagnosis.
Neuromuscular Diseases
Myoadenylate deaminase deficiency: inherited and acquired forms.
Neuromuscular Diseases
Myoadenylate deaminase deficiency: primary and secondary types.
Neuromuscular Diseases
Myotonia congenita and myoadenylate deaminase deficiency: case report.
Neuromuscular Diseases
[AMP-aminohydrolase of skeletal muscles in muscular diseases]
Neuromuscular Diseases
[The histochemical formation of the myoadenylate deaminase reaction in human skeletal musculature]
Obesity
AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases.
Obesity
Association of C34T AMPD1 gene polymorphism with features of metabolic syndrome in patients with coronary artery disease or heart failure.
Obesity
High expression of AMPD2 and obesity are associated with poor prognosis in colorectal cancer.
Olivopontocerebellar Atrophies
Myoadenylate deaminase deficiency in twins with recessive olivopontocerebellar atrophy.
Osteoarthritis
[Clinico-pathogenetic significance of enzymes regulating nucleic metabolism in erythrocyte lysates and sera of patients with osteoarthrosis]
Overweight
High expression of AMPD2 and obesity are associated with poor prognosis in colorectal cancer.
Pancreatitis
Kinetic properties of AMP deaminase in acute experimental pancreatitis.
Paralysis
Effects of growth medium, electrical stimulation and paralysis on various enzyme activities in cultured rat muscle cells. Comparison with activities in rat muscles in vivo.
Paralysis
NUCLEOTIDES AND ADENOSINE MONOPHOSPHATE DEAMINASE ACTIVITY OF MUSCLE IN PRIMARY HYPOKALAEMIC PERIODIC PARALYSIS.
Paraplegia
Clinical and genetic spectrum of AMPD2-related pontocerebellar hypoplasia type 9.
Parasitic Diseases
In vivo, attenuation of schistosome cercarial development and disturbance of egg laying capacity in Biomphalaria alexandrina using sublethal concentrations of plant molluscicides.
Perinatal Death
Insertion of a knockout-first cassette in Ampd1 gene leads to neonatal death by disruption of neighboring genes expression.
Pneumonia
Remote reperfusion lung injury is associated with AMP deaminase 3 activation and attenuated by inosine monophosphate.
Polycystic Kidney, Autosomal Dominant
Super-enhancer-driven metabolic reprogramming promotes cystogenesis in autosomal dominant polycystic kidney disease.
Polymyositis
Molecular analysis of acquired myoadenylate deaminase deficiency in polymyositis (idiopathic inflammatory myopathy).
Prediabetic State
A novel method for testing association of multiple genetic markers with a multinomial trait.
Proteinuria
Proteinuria in AMPD2-deficient mice.
Pulmonary Heart Disease
[The effect of aminophylline on plasma oxypurines in patients with bronchial asthma or cor pulmonale]
Reperfusion Injury
IMP and AMP deaminase in reperfusion injury down-regulates neutrophil recruitment.
Reperfusion Injury
Remote reperfusion lung injury is associated with AMP deaminase 3 activation and attenuated by inosine monophosphate.
Rhabdomyolysis
Acute myopathy associated with chronic licorice ingestion: reversible loss of myoadenylate deaminase activity.
Rhabdomyolysis
Influence on myoadenylate deaminase function in rat skeletal muscle after homologous and heterologous immunization with the purified enzyme.
Rhabdomyolysis
McArdle disease causing rhabdomyolysis following vaginal delivery.
Rhabdomyolysis
Myoadenylate deaminase deficiency with severe rhabdomyolysis.
Rhabdomyolysis
Rhabdomyolysis associated with malaria tertiana in a patient with myoadenylate deaminase deficiency.
Rhabdomyolysis
Severe rhabdomyolysis caused by Plasmodium vivax malaria in the Brazilian Amazon.
Rhabdomyolysis
Type 2a fibre rhabdomyolysis in myoadenylate deaminase deficiency.
Sarcoglycanopathies
Cardiac involvement in primary myopathies.
Sarcoma
Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma.
Scleroderma, Diffuse
Myoadenylate deaminase deficiency in a patient with progressive systemic sclerosis.
Scoliosis
Association Study between Idiopathic Scoliosis and Polymorphic Variants of VDR, IGF-1, and AMPD1 Genes.
Sepsis
Effects of the 34C>T Variant of the AMPD1 Gene on Immune Function, Multi-Organ Dysfunction, and Mortality in Sepsis Patients.
Sickle Cell Trait
Genetic polymorphisms associated with exertional rhabdomyolysis.
Spinal Muscular Atrophies of Childhood
AMP deaminase activity of skeletal muscle in neuromuscular disorders in childhood. Histochemical and biochemical studies.
Starvation
Activation of trout gill AMP deaminase by an endogenous proteinase--II. Modification of the properties of the enzyme during starvation, pollution and salinity changes.
Starvation
Adenylic deaminase activity in B-avitaminosis and in starvation.
Starvation
Amino acid metabolism enzyme activities in the obese Zucker rat.
Starvation
AMP deaminase in Dictyostelium discoideum: increase in activity following nutrient deprivation induced by starvation or hadacidin.
Starvation
Distribution of amino acids and amino-acid enzymes in whole kidney and renal cortex. Effect of 24-h starvation.
Starvation
Effect of 24-hour starvation on amino acid pool composition and enzyme activities of rat brown adipose tissue.
Starvation
Effect of starvation on catalytic potential of AMP-deaminase in skeletal muscle of the frog Rana hexadactyla Lesson.
Starvation
Influence of diet and obesity on placental amino acid enzyme activities in the rat.
Starvation
Regulation of platelet AMP deaminase activity in situ.
Tetanus
Activation of AMP aminohydrolase during skeletal-muscle contraction.
thymidine kinase deficiency
AMP deaminase and thymidine kinase deficiencies in a mutant mouse S49 cell clone.
Thyroid Cancer, Papillary
Expression of serum AMPD1 in thyroid carcinoma and its clinical significance.
Thyroid Neoplasms
Expression of serum AMPD1 in thyroid carcinoma and its clinical significance.
Tooth Abnormalities
Novel AMPD2 mutation in pontocerebellar hypoplasia, dysmorphisms, and teeth abnormalities.
Ventricular Dysfunction
Xanthine oxidoreductase-mediated injury is amplified by upregulated AMP deaminase in type 2 diabetic rat hearts under the condition of pressure overload.
Ventricular Dysfunction, Left
A common variant of the AMPD1 gene predicts improved survival in patients with ischemic left ventricular dysfunction.
Vision Disorders
Clinical and genetic spectrum of AMPD2-related pontocerebellar hypoplasia type 9.
Whooping Cough
Adenosine stimulation of AMP deaminase activity in adult rat cardiac myocytes.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
3.5.4.6 AMP deaminase
more
top
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable). 
